Intranasal Dexmed vs Intranasal Midazolam via Mucosal atomiser for Emergence Agitatio
Not Applicable
- Conditions
- Health Condition 1: Q120- Congenital cataract
- Registration Number
- CTRI/2020/03/023752
- Lead Sponsor
- DIRECTOR PGIMER CHANDIGARH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
ASA 1 and ASA 2 patients undergoing cataract surgery
Exclusion Criteria
1 ORGAN DYSFUCNTION
2 CARDIAC ARRYTHMIAS OR CONGENTIAL DISEASE
3 DEVELEOPMENTAL DELAY
4 NEUROLOGICAL DISEASES
5 ANY ACTIVE URTI
6 CHILDREN AT RISK OF UPPER AIRWAY OBSTRUCTION
7 KNOWN ALLERGY TO DEXMEDTOMIDINE OR MIDAZOLAM
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence Of Emergence AgitationTimepoint: @ 0 minute, 5 minute, 10 minute , 15 minute , 20 minute, 25 minute, 30 minutes. upto 6 hours post op
- Secondary Outcome Measures
Name Time Method Face Mask AcceptanceTimepoint: At time of induction of anaesthesia;Parent/Guardian SatisfactionTimepoint: 6 hours after surgery;Postoperative PainTimepoint: 0 MIN, 5 MIN, 10MIN, 15 MIN, 20 MIN, 25 MIN , 30 MIN, Till 6 hours post surgery;Pre-procedural SedationTimepoint: 0 mins before surgery;Preoperative AnxietyTimepoint: 30 Mins, 20 Mins, 10 Mins, 0 Mins Before surgery
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of intranasal dexmedetomidine in preventing emergence agitation in pediatric patients with congenital cataract?
How does the efficacy of intranasal midazolam compare to standard-of-care benzodiazepines for emergence agitation in pediatric cataract surgery?
Which biomarkers correlate with response to mucosal atomization device delivery of alpha-2 adrenergic agonists in pediatric anesthesia?
What adverse events are associated with intranasal administration of sedatives in children undergoing sevoflurane-based cataract surgery?
Are there alternative combination therapies involving dexmedetomidine for emergence agitation in RAS mutant pediatric ophthalmic procedures?